Generation Bio Co.
NASDAQ:GBIO
6.13 (USD) • At close August 26, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Revenue
| 19.892 | 5.904 | 0 | 0 | 0 | 0 | 0.036 |
| Cost of Revenue
| 4.931 | 5.263 | 5.13 | 4.532 | 3.432 | 1.864 | 0 |
| Gross Profit
| 19.892 | -71.035 | -5.13 | -4.532 | -3.432 | -1.864 | 0.036 |
| Gross Profit Ratio
| 1 | -12.032 | 0 | 0 | 0 | 0 | 1 |
| Reseach & Development Expenses
| 61.305 | 93.617 | 96.718 | 85.247 | 58.532 | 50.134 | 28.152 |
| General & Administrative Expenses
| 37.78 | 50.85 | 44.464 | 33.854 | 22.582 | 12.168 | 9.178 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 37.78 | 50.85 | 44.464 | 33.854 | 22.582 | 12.168 | 9.178 |
| Other Expenses
| 63.197 | -76.939 | -70.564 | -4.532 | -3.432 | 0 | 0 |
| Operating Expenses
| 162.282 | 67.528 | 70.618 | 114.569 | 77.682 | 62.302 | 37.33 |
| Operating Income
| -142.39 | -138.563 | -141.182 | -119.101 | -81.114 | -62.302 | -37.294 |
| Operating Income Ratio
| -7.158 | -23.469 | 0 | 0 | 0 | 0 | -1,035.944 |
| Total Other Income Expenses Net
| 10.722 | 11.951 | 4.543 | -0.05 | 0.591 | 0.985 | 1.491 |
| Income Before Tax
| -131.668 | -126.612 | -136.639 | -119.151 | -80.523 | -61.317 | -35.803 |
| Income Before Tax Ratio
| -6.619 | -21.445 | 0 | 0 | 0 | 0 | -994.528 |
| Income Tax Expense
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income
| -131.668 | -126.612 | -136.639 | -119.151 | -80.523 | -60.332 | -35.803 |
| Net Income Ratio
| -6.619 | -21.445 | 0 | 0 | 0 | 0 | -994.528 |
| EPS
| -19.76 | -19.63 | -23.51 | -21.17 | -29.54 | -13.1 | -18.2 |
| EPS Diluted
| -19.76 | -19.63 | -23.51 | -21.17 | -29.54 | -13.1 | -18.2 |
| EBITDA
| -74.262 | -133.3 | -136.052 | -114.569 | -77.682 | -60.438 | -36.947 |
| EBITDA Ratio
| -3.733 | -22.578 | 0 | 0 | 0 | 0 | -1,026.306 |